The Council of Lyons in Lyon, France restricted lepers from pubic association
In 583 BCE, the Council of Lyons in Lyon, France restricted lepers from freely associating with healthy persons.
Chinese healers created the first antibiotic to treat boils
Around 600 BCE, Chinese healers created the first antibiotic – moldy soybean curds – to treat boils.
Hippocrates described mumps, diphtheria, epidemic jaundice, and other conditions
Around 500 BCE, Hippocrates, a pioneering physician in the history of Medicine, and considered as the principal author…
Chinese growers used powdered chrysanthemum (pyrethrins) as the first insecticide
Around 100 BCE, Chinese growers used powdered chrysanthemum (pyrethrins) as the first insecticide.
Animal Biosecurity and Agro-Defense Program launched at Auburn
On Oct. 2, 2021, the Auburn University College of Veterinary Medicine was announced as the home to the…
Humanigen submitted all planned modules forpotential conditional Marketing Authorization from UKﾒs MHRA
On Oct. 1, 2021, Humanigen announced it had submitted all the planned modules as well as a risk…
FDA approved Kiteﾒs Tecartusﾮ as first and only Car T for adults with Relapsed or Refractory B-cell ALL
On Oct. 1, 2021, Kite, a Gilead Company, announced the U.S. Food and Drug Administration had granted approval…
Relief reported that collaboration partner announced a second favorable safety report for ZYESAMI(TM) in Patients with COVID-19
On Sept. 30, 2021, RELIEF THERAPEUTICS reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals,…
Trevena announced results of TRV027 proof-of-concept study in COVID-19 patients
On Sept. 30, 2021, Trevena announced data from 30 patients enrolled in the proof-of-concept study of TRV027, the…
U.S. FDA cleared Naeotom Alpha, worldﾒs first photon-counting computer tomograph
On Sept. 30 2021, Siemens Healthineers announced the Food and Drug Administration (FDA) 510 (k) clearance of the…
Colossal, a de-extinction company was founded to bring the Woolly Mammoth back to life
On Sept. 29, 2021, Colossal, a de-extinction company that is combining the science of genetics with the business…
VBI Vaccines announced preclinical data and Initiation of VBI-2905 clinical trial targeting broadened immunity against COVID-19
On Sept. 29, 2021, VBI Vaccines announced positive results from multiple preclinical studies against several COVID-19 variants of…
Cepheid received Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B and RSV combination test
On Sept. 29, 2021, Cepheid announced it had received Emergency Use Authorization from the U.S. Food & Drug…
TGen part of $60 million grant awarded to UArizona to create national Precision Aging Network
On Sept. 28, 2021, TGen, an affiliate of City of Hope, will use its MindCrowd website portal to…
AIM ImmunoTech submitted pre-IND application to FDA for phase 2 clinical studies of Ampligen as potential therapeutic for COVID-19
On Sept. 28, 2021, AIM ImmunoTech announced that is had submitted a Pre-Investigational New Drug application (Pre-IND) to…
University of Missouri researchers identified mutations of Delta, Delta Plus variants
On Sept. 28, 2021, the University of Missouri researcher Kamlendra Singh led a team that analyzed protein sequences…
Over half of U.S. children have detectable levels of lead in their blood in Quest Diagnostics study published in JAMA
On Sept. 28, 2021, Quest Diagnostics reported that one in two (50.5%) American children under six years of…
Soligenix announced publication demonstrating efficacy and broad neutralizing activity of its COVID-19 Vaccine
On Sept. 28, 2021, Soligenix announced publication of pre-clinical immunogenicity studies for CiVax (heat stable COVID-19 vaccine program)…
Pfizer and BioNTech submitted initial data to FDA from pivotal trial of COVID-19 vaccine in children 5 to <12 years of age
On Sept. 28, 2021, Pfizer and BioNTech announced they had submitted data to the U.S. Food and Drug…
Relief reported that collaboration partner announced improved survival in highly comorbid COVID-19 patients treated with ZYESAMITM
On Sept. 27, 2021, RELIEF THERAPEUTICS reported its U.S. collaboration partner, NRx Pharmaceuticals, had announced top line data…
Pfizer started global phase 2/3 EPIC-PEP study of novel COVID-19 oral antiviral candidate for post-exposure prophylaxis in adults
On Sept. 27, 2021, Pfizer announced the start of the Phase 2/3 EPIC-PEP (Evaluation of Protease Inhibition for…
Twist Bioscience single domain antibody TB202-3 showed potent binding to multiple strains of SARS-CoV-2
On Sept. 23, 2021, Twist Bioscience reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to…
Pfizer and BioNTech received first U.S. FDA Emergency Use Authorization of a COVID-19 vaccine booster
On Sept. 23, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) has authorized…
Clover Biopharmaceuticals’s vaccine using Dynavax’s CpG 1018 adjuvant met primary and secondary efficacy endpoints
On Sept. 22, 2021, Dynavax Technologies announced that Clover Biopharmaceuticals reported positive data for their protein-based COVID-19 vaccine…
The Medicines Patent Pool secured its first licence for malaria, tuberculosis and hepatitis C
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
Eiger BioPharma announced interim analysis of dosing of Peginterferon Lambda in phase 3 TOGETHER study
On Sept. 20, 2021, Eiger BioPharmaceuticals announced announced that Peginterferon Lambda (Lambda) will be added to the ongoing,…
Pfizer and BioNTech announced positive topline results from pivotal trial of COVID-19 vaccine in children 5 to 11 years
On Sept. 20, 2021, Pfizer and BioNTech announced results from a Phase 2/3 trial showing a favorable safety…
Great cats tested presumptive positive for COVID-19 at the Smithsonian’s National Zoo
On Sept. 17, 2021, the lions and tigers at the Smithsonian’s National Zoo were reported testing presumptive positive…
CDC to invest $2.1 billion to protect patients and healthcare workers from COVID-19 and future infectious diseases
On Sept. 17, 2021, the Centers for Disease Control and Prevention (CDC) announced a $2.1 billion investment to…
The COVID-19 pandemic has caused the biggest decrease in life expectancy since World War II
On Sept. 17, 2021, Oxfordﾒs Leverhulme Centre for Demographic Science reported the COVID-19 pandemic triggered life expectancy losses…